Home › Semantics 101: Goldman's Biotech Downgrade and the New Biotech Consensus
 

Keywords :   


Semantics 101: Goldman's Biotech Downgrade and the New Biotech Consensus

2014-01-06 17:56:12| Biotech - Topix.net

We see current valuations on the majority of the stocks as fair and expect earnings rather than multiple expansion to dictate future stock performance.

Tags: consensus biotech semantics downgrade

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
26.06SWANA Publishes Report on the Performance of Seattles Zero Waste System
More »